A single-center prospective study on pain alleviation during peroral upper endoscopy with an ultrathin endoscope.

Reduction of discomfort undergoing upper endoscopy Transnasal ultrathin esophagogastroduodenoscopy) Upper GI tract

Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
21 Sep 2023
Historique:
received: 01 03 2023
accepted: 20 09 2023
medline: 25 9 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: epublish

Résumé

The efficacy of transnasal endoscopy using an ultrathin endoscope has been reported in several studies. However, few studies regarding peroral endoscopy with ultrathin endoscopes with high resolution have been reported. This study investigates the pain alleviation of peroral endoscopy with an ultrathin endoscope. Patients with a history of peroral endoscopy using a conventional, normal-diameter scope with no sedation who underwent peroral esophagogastroduodenoscopy (EGD) using a thin scope between April-July 2022 were included in this study. After the procedure, the patients completed a questionnaire evaluating pain during the examination and willingness to repeat the procedure. The physicians were surveyed regarding their level of satisfaction. The primary endpoint was patient satisfaction, which corresponded to the rate of patients who rated the thin endoscope as more comfortable or somewhat more comfortable than the previously-used, conventional endoscope. One hundred and forty-five patients were included in the analyses. Patient satisfaction was achieved in 86.2% (125/145) of patients. The median visual analog scale pain score was 3 (0-7) points in this study, which is significantly lower than the pain score after the previous endoscopy (5 (0-10) points; p < 0.001). In addition, 96% (24/25) of patients who underwent EGD by an expert and 95.8% (115/120) who underwent EGD by a non-expert were willing to repeat endoscopy using the thin scope (p = 0.69). Peroral endoscopy using a thin scope reduces patient pain regardless of the endoscopist's experience.

Sections du résumé

BACKGROUND BACKGROUND
The efficacy of transnasal endoscopy using an ultrathin endoscope has been reported in several studies. However, few studies regarding peroral endoscopy with ultrathin endoscopes with high resolution have been reported. This study investigates the pain alleviation of peroral endoscopy with an ultrathin endoscope.
METHODS METHODS
Patients with a history of peroral endoscopy using a conventional, normal-diameter scope with no sedation who underwent peroral esophagogastroduodenoscopy (EGD) using a thin scope between April-July 2022 were included in this study. After the procedure, the patients completed a questionnaire evaluating pain during the examination and willingness to repeat the procedure. The physicians were surveyed regarding their level of satisfaction. The primary endpoint was patient satisfaction, which corresponded to the rate of patients who rated the thin endoscope as more comfortable or somewhat more comfortable than the previously-used, conventional endoscope.
RESULTS RESULTS
One hundred and forty-five patients were included in the analyses. Patient satisfaction was achieved in 86.2% (125/145) of patients. The median visual analog scale pain score was 3 (0-7) points in this study, which is significantly lower than the pain score after the previous endoscopy (5 (0-10) points; p < 0.001). In addition, 96% (24/25) of patients who underwent EGD by an expert and 95.8% (115/120) who underwent EGD by a non-expert were willing to repeat endoscopy using the thin scope (p = 0.69).
CONCLUSION CONCLUSIONS
Peroral endoscopy using a thin scope reduces patient pain regardless of the endoscopist's experience.

Identifiants

pubmed: 37735366
doi: 10.1186/s12876-023-02965-3
pii: 10.1186/s12876-023-02965-3
pmc: PMC10514927
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Gastrointest Endosc. 1999 Mar;49(3 Pt 1):285-91
pubmed: 10049409
Gastrointest Endosc. 1999 Mar;49(3 Pt 1):279-84
pubmed: 10049408
Frontline Gastroenterol. 2016 Oct;7(4):246-256
pubmed: 28839865
Gastrointest Endosc. 2008 May;67(6):910-23
pubmed: 18440381
Endoscopy. 2001 Apr;33(4):311-6
pubmed: 11315891
J Clin Gastroenterol. 2010 Jan;44(1):12-7
pubmed: 19661817
J Gastroenterol Hepatol. 2007 Apr;22(4):482-5
pubmed: 17376037
Dig Dis Sci. 2022 Jun;67(6):1937-1947
pubmed: 35239094
Hepatogastroenterology. 2011 May-Jun;58(107-108):842-5
pubmed: 21830401
Gastrointest Endosc. 2015 Nov;82(5):782-92
pubmed: 26371850
Gastrointest Endosc. 1999 Mar;49(3 Pt 1):292-6
pubmed: 10049410
Dig Endosc. 2016 Apr;28 Suppl 1:25-31
pubmed: 26792612
Dig Endosc. 2009 Jul;21(3):141-6
pubmed: 19691759
J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:33-6
pubmed: 25521731
Dig Endosc. 2021 Jan;33(1):21-53
pubmed: 33124106

Auteurs

Iwao Aya (I)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.
Health Management Center, Toranomon Hospital, Tokyo, Japan.

Ryoji Ichijima (R)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan. ryoji0331@yahoo.co.jp.

Tomomi Sugita (T)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Masako Nakayama (M)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Ayaka Takasu (A)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Kanako Ogura (K)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Takuji Gotoda (T)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Hirofumi Kogure (H)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH